Experts warn fake ‘skinny jabs’ are circulating in the UK. Here are 9 red flags to watch for – and what to do if you think ...
Karen McGonigal, 53, died days after she was illegally administered a dose of semaglutide - the powerful ingredient behind ...
Karen McGonigal's three daughters say she became "desperate" to lose weight after a long-term relationship ended - with ...
Eli Lilly and Co. has reached an agreement with pharmaceutical Cipla to market tirzepatide, the active ingredient in Lilly’s ...
Novo Nordisk faces headwinds and leadership shifts, while Structure Therapeutics eyes pivotal obesity-drug data later this year.
Shares of Cipla fell more than 3 per cent on Friday after the drugmaker announced a partnership with US pharmaceutical major ...
In a move aimed at expanding access to obesity and diabetes care in India, Eli Lilly and Company (India) Pvt. Ltd. (Lilly) ...
Analysts say that while the deal is a positive for the stock, it has already been priced in and investors are now resorting ...
Brokerage firm Nuvama Institutional Equities believes Cipla, with its strong field force and distribution network, could ...
Cipla enters obesity and diabetes drug market with Eli Lilly's tirzepatide 'Yurpeak'; Nuvama retains 'Hold' on Cipla stock, ...
5d
First Mounjaro, now Yurpeak: Eli Lilly ties up with Cipla to bring weight loss drug under new name
Under the agreement, Eli Lilly will continue to market tirzepatide under brand name Mounjaro, while Cipla will have the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback